Repair

Global soft tissue repair industry expected to reach $17.2 billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Soft Tissue Repair Market by Product (Mesh/Tissue Patch, Allograft, Xenograft, Suture Anchor, Interference Screw, Laparoscopic Instruments), Application (Hernia, Dural, Orthopedic, Skin, Dental , vaginal, breast augmentation), and Region – Forecast to 2027” report has been added to from ResearchAndMarkets.com offer.

Analyst expects soft tissue repair market to reach USD 17.2 billion by 2027, from USD 13.6 billion in 2022, growing at a CAGR of 4.7% during the period forecast.

Tissue Patched/Mashes accounted for the largest soft tissue repair market share by product type

On the basis of product, the soft tissue repair market is segmented into tissue patch/mash and laparoscopic instrument injectors. In 2021, Tissue Patch/Mesh accounted for the largest share of 91.9% of the soft tissue repair market. This product segment is expected to reach USD 15,892.3 million by 2027 from USD 12,547.2 million in 2022, at a CAGR of 4.8% during the forecast period. The large share of this segment is attributed to the increasing use of synthetic mesh in different types of orthopedic surgeries as it reduces the surgical time.

Hernia Repair accounted for the largest soft tissue repair market share by application

Based on type of application, the soft tissue repair market is segmented into hernia repair, dural repair, vaginal sling procedures, skin repair, orthopedic repair, dental repair, breast reconstruction repair and others apps. In 2021, hernia repair is estimated to account for the largest share of 26.5% of the soft tissue repair market, by application. The increasing incidence of hernia cases, sports injuries and the increasing prevalence of lifestyle disorders, such as arthritis, osteoporosis and obesity (leading to orthopedic problems), are some of the major factors responsible for the growth in the number of soft tissue repair surgeries. performed globally.

The hospital segment accounted for the largest soft tissue repair market share by end user

On the basis of end users, the soft tissue repair market is segmented into hospitals, clinics, and other end users (ambulatory surgery centers, urgent care centers, burn care centers, and research institutes). The hospital segment accounted for the largest share of 93.3% of the soft tissue repair market in 2021. This is mainly attributed to the growing number of surgeries taking place globally owing to the increase in geriatric population and the incidence of various diseases. Additionally, the growing need to control blood loss and achieve effective hemostasis and wound closure in cases of trauma, injury, or surgical procedures is driving the increasing adoption of soft tissue repair products. by surgeons.

North America segment accounted for largest soft tissue repair market share by region

Based on region, the soft tissue repair market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In 2021, North America accounted for the largest share of 43.5% of the soft tissue repair market, followed by Europe, Asia-Pacific, Latin America, Middle East and Africa. The large share of the North America market is attributed to the presence of an advanced healthcare system in the region, high and growing number of surgical procedures, increased adoption of advanced products, and the presence of several players in market leader in the United States.

Market dynamics

Drivers

  • Rising aging population and obesity rate

  • Growing incidence of sports injuries

  • Strong focus on R&D

  • Increase in the volume of surgeries and increase in the prevalence of serious trauma

Constraints

  • Unfavorable repayment scenario

  • High costs of products and procedures

Opportunities

  • Growing Adoption of Advanced Soft Tissue Repair Products in Emerging Markets

  • Increasing use of combined materials to improve product efficiency

Challenges

  • Rigorous regulatory framework

  • Need for qualified personnel

Companies cited

  • Acell Inc.

  • Acera Surgical Inc.

  • Aroa Biosurgery Ltd.

  • Arthrex inc.

  • Baxter International, Inc.

  • Becton, Dickinson & Company

  • Betatech Medical

  • Biocer Entwicklungs-GmbH

  • Conmed Company

  • Cryolife Inc.

  • Integra Lifesciences Holdings Corporation

  • Isto Biologics

  • Johnson & Johnson

  • Lifenet Health Inc.

  • Medtronic plc.

  • Meril Life Sciences Pvt. ltd.

  • MiMedx

  • Organogenesis Inc.

  • Orthocell Ltd.

  • RTI surgery

  • Samyang Holdings Corporation

  • Smith & Nephew plc

  • Stryker Company

  • Tissue Regenix Group plc

  • Zimmer Biomet

For more information about this report visit https://www.researchandmarkets.com/r/1kl4ia